NHS Blood and Transplant
94 capabilities
Verified Oct 2026
One of 2,018 in United Kingdom
Send one structured enquiry and we chase the reply for you. No cold email, no chasing.
Details
Red Cell Immunohaematology, NHS Blood and Transplant, 75 Cranmer Terrace, Tooting
Tooting SW17 0RB , United Kingdom
Tooting SW17 0RB , United Kingdom
Accreditation
Active
UKAS
8740
nhsbt.nhs.uk
Prefer to enquire through us? Send an enquiry
Accreditation Details
Accreditation Body
UKAS
Number
8740
Status
ActiveAccreditation is granted under EU Regulation 765/2008 and assessed against ISO/IEC 17025. Data sourced from official UKAS records.
Download Scope PDFOther locations
Test Capabilities (94)
| Standard Reference | Description | Category |
|---|---|---|
| MEASUREMENT | Measurement | Electrical |
| ABO, Rh D, C, c, D, E, e | ABO, Rh D, C, c, D, E, e | Hematology |
| ABO, Rh D, C, c, D, E, e K, C w | ABO, Rh D, C, c, D, E, e K, C w | Hematology |
| ABO, Rh D, C, c, D, E, e K, Cw, Fya, Fyb, Jka, Jkb, Kpa, Kpb, Lea, Leb, Lua, Lub, M, N, S, s, P1, Wra | ABO, Rh D, C, c, D, E, e K, Cw, Fya, Fyb, Jka, Jkb, Kpa, Kpb, Lea, Leb, Lua, Lub, M, N, S, s, P1, Wra | Hematology |
| Crossmatching | Crossmatching | Hematology |
| Fya, Fyb, Jka, Jkb, Kpa, Kpb, Lea, Leb, Lua, Lub, M, N, S, s, P1, Wra | Fya, Fyb, Jka, Jkb, Kpa, Kpb, Lea, Leb, Lua, Lub, M, N, S, s, P1, Wra | Hematology |
| Investigation of Drug induced haemolytic anaemia | Investigation of Drug induced haemolytic anaemia | Hematology |
| K, C w , Blood group determination | K, C w , Blood group determination | Hematology |
| Weak and partial D measurement | Weak and partial D measurement | Hematology |
| Anti-A and Anti-B | Anti-A and Anti-B | Immunology / Serology |
| Anti-C, Anti-c, Anti-E, Anti-e, Anti-K, anti-C w Anti-M, Anti-S, Anti-s, Anti-U, Anti-Fya, Anti- Fyb, Anti-Fy3, Anti-Jka, Anti- Jkb | Anti-C, Anti-c, Anti-E, Anti-e, Anti-K, anti-C w Anti-M, Anti-S, Anti-s, Anti-U, Anti-Fya, Anti- Fyb, Anti-Fy3, Anti-Jka, Anti- Jkb | Immunology / Serology |
| Antibodies to high frequency antigens | Antibodies to high frequency antigens | Immunology / Serology |
| Antibody titration for transplant | Antibody titration for transplant | Immunology / Serology |
| Antibody titration in pregnancy | Antibody titration in pregnancy | Immunology / Serology |
| Autoantibodies | autoantibodies | Immunology / Serology |
| Autoantibodies measurement | Autoantibodies measurement | Immunology / Serology |
| Blood Group determination | Blood Group determination | Immunology / Serology |
| Confirmation of red cell antigen phenotype: A, B, A1, D, C, c, E, e, C w , M, N, S, s, P1, Lu a , K, k, Kp a , Le a , Le b , Fy a , Fy b , Jk a , Jk b | Confirmation of red cell antigen phenotype: A, B, A1, D, C, c, E, e, C w , M, N, S, s, P1, Lu a , K, k, Kp a , Le a , Le b , Fy a , Fy b , Jk a , Jk b | Immunology / Serology |
| Detection and identification of HLA specific antibodies | Detection and identification of HLA specific antibodies | Immunology / Serology |
| Detection and identification of HNA specific antibodies: HLA-1a, 1b, 1c, 1d, CD16, HNA-2, CD177, HNA-3, -4, -5 or CD11/18 measurement | Detection and identification of HNA specific antibodies: HLA-1a, 1b, 1c, 1d, CD16, HNA-2, CD177, HNA-3, -4, -5 or CD11/18 measurement | Immunology / Serology |
| Detection of Heparin associated platelet antibodies: PF4 (HAT13G, HAT45G, X- HAT13 or X-HAT45) measurement | Detection of Heparin associated platelet antibodies: PF4 (IgG/IgM) | Immunology / Serology |
| Determination of antibodies directed to all known blood group antigens | Determination of antibodies directed to all known blood group antigens | Immunology / Serology |
| HLA Typing: HLA Class I Type | HLA typing: | 5. HLA Class I and Class II typing | Immunology / Serology |
| High Titre Low Avidity antibodies | High Titre Low Avidity antibodies | Immunology / Serology |
| Quantification of antibodies: Anti-c / Anti-D | Quantification of antibodies: Anti-c / Anti-D | Immunology / Serology |
| Red Cell Immunohaematology investigations of for the purpose of clinical diagnosis | Red Cell Immunohaematology investigations of for the purpose of clinical diagnosis | Immunology / Serology |
| Detection of CCR5 delta32 mutation measurement | Detection of CCR5 delta32 mutation measurement | Molecular Diagnostics / PCR |
| Detection of red cell antigen phenotype: Blood Group sequencing principally RHD and RHCE genes to identify rare and complex variants | Detection of red cell antigen phenotype: Blood Group sequencing principally RHD and RHCE genes to identify rare and complex variants | Molecular Diagnostics / PCR |
| Detection of the presence of the RHD*Weak D type 1 and 2 alleles | Detection of the presence of the RHD*Weak D type 1 and 2 alleles | Molecular Diagnostics / PCR |
| Determination of extended red cell antigen types for Haemoglobinopathy patients | Determination of extended red cell antigen types for Haemoglobinopathy patients | Molecular Diagnostics / PCR |
| Determination of fetal blood group genotype: D, C, c, E, K1 | Determination of fetal blood group genotype: D, C, c, E, K1 | Molecular Diagnostics / PCR |
| Determination of red cell antigen type: C, c, E, e, M, N, S, s, U, K, k, Kpa/Kpb, Jsa, Jsb, Fya, Fyb, Jka, Jkb, Doa, Dob, Lua, Lub | Determination of red cell antigen type: D, C, c, E, e, V, VS M, N, S, s, U, K, k, Kpa/Kpb, Jsa, Jsb Fya, Fyb, Fyx, Jka, Jkb, Doa, Dob, Hy+/-, Joa, Job Lua, Lub, Dia/b, Coa/b Lw1/Lw2 | Molecular Diagnostics / PCR |
| Determination of red cell genotypes: RHCE: C, C W , c, E, e; KEL1(K), KEL2(k), JK1(Jk a ), JK2(Jk b ), FY1(Fy a ), FY2(Fy b ), FYnull(Fy a -, Fy b -), FYX(Fy bweak ), MNS1(M), MNS2(N), MNS3(S), MNS4(s), DO1(Do a ), DO2(Do b ) | Determination of red cell genotypes: RHCE: C, C W , c, E, e; KEL1(K), KEL2(k), JK1(Jk a ), JK2(Jk b ), FY1(Fy a ), FY2(Fy b ), FYnull(Fy a -, Fy b -), FYX(Fy bweak ), MNS1(M), MNS2(N), MNS3(S), MNS4(s), DO1(Do a ), DO2(Do b ) | Molecular Diagnostics / PCR |
| HFE typing: Gene positions - 63/282 | HFE typing: Gene positions - 63/282 | Molecular Diagnostics / PCR |
| HLA typing of B*27 | HLA typing of B*27 | Molecular Diagnostics / PCR |
| HLA-A, -B, -C, -DRB1, -3 -4, - 5, -DQA1, -DQB1, -DPA1, - DPB1 | HLA-A, -B, -C, -DRB1, -3 -4, - 5, -DQA1, -DQB1, -DPA1, - DPB1 | Molecular Diagnostics / PCR |
| HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 measurement | HLA-A, -B, -C, -DRB1, -DQB1, -DPB1 measurement | Molecular Diagnostics / PCR |
| HNA Typing: HNA -1, - 3, -4, -5 | HNA Typing: HNA -1, - 3, -4, -5 | Molecular Diagnostics / PCR |
| HPA Typing: HPA -1, - 2, - 3, -4, -5, -6, -9, - 15 | HPA typing: HPA -1, -2, -3, -4, -5, -6. -9, - 15 measurement | Molecular Diagnostics / PCR |
| HPA typing (high throughput) | HPA typing (high throughput) | Molecular Diagnostics / PCR |
| HPA-1, -2, -3, -4, -5 -15 | HPA-1, -2, -3, -4, -5 -15 | Molecular Diagnostics / PCR |
| Molecular investigations for the purpose of clinical diagnosis | Molecular investigations for the purpose of clinical diagnosis | Molecular Diagnostics / PCR |
| (phenotype) | (phenotype) | Other |
| ABO measurement | ABO measurement | Other |
| Additional antigens for rare donor confirmatory testing: Kp b , Js a , Js b | Additional antigens for rare donor confirmatory testing: Kp b , Js a , Js b | Other |
| Co a , Co b | Co a , Co b | Other |
| Confirmation of identification of cord blood units during issue | Confirmation of identification of cord blood units during issue | Other |
| DNA sequence | DNA sequence | Other |
| Detection and Identification of: Plasmodium species: Plasmodium falciparum | Detection and Identification of: Plasmodium species: Plasmodium falciparum | Other |
| Detection and identification of HNA-3a/b specific antibody | Detection and identification of HNA-3a/b specific antibody | Other |
| Detection and identification of HPA specific antibodies: GPIV, HLA - A, - B, - C, GPIIb/IIIa, GPIb/IX, GPIa/IIa, (which can define HPA -1, -2, - 3, -4, -5) | Detection and identification of HPA specific antibodies: GPIV, HLA - A, - B, - C, GPIIb/IIIa, GPIb/IX, GPIa/IIa, (which can define HPA -1, -2, - 3, -4, -5) | Other |
| Detection of Granulocyte specific antibodies | Detection of Granulocyte specific antibodies | Other |
| Detection of Granulocyte specific antibodies including anti-HNA -1, CD16, -2, -3, -4 - 5 measurement | Detection of Granulocyte specific antibodies including anti-HNA -1, CD16, -2, -3, -4 - 5 measurement | Other |
| Detection of HNA incompatibilities measurement | Detection of HNA incompatibilities measurement | Other |
| Detection of HNA phenotypes: HNA -1, -2 measurement | Detection of HNA phenotypes: HNA -1, -2 measurement | Other |
| Detection of HPA incompatibility | Detection of HPA incompatibility | Other |
| Detection of HPA incompatibility measurement | Detection of HPA incompatibility measurement | Other |
| Detection of HPA specific antibodies including: HPA -1, -2, - 3, -5, -6, -9 15 | Detection of HPA specific antibodies including: HPA -1, -2, - 3, -5, -6, -9 15 | Other |
| Detection of HPA specific antibodies: HPA -1, -2, - 3, -5, -6 -9 - 15 | Detection of HPA specific antibodies: HPA -1, -2, - 3, -5, -6 -9 - 15 | Other |
| Detection of IgG HLA specific antibodies to donor T and B lymphocytes | Detection of IgG HLA specific antibodies to donor T and B lymphocytes | Other |
| Detection of IgG HLA specific antibodies to donor T and B lymphocytes measurement | Detection of IgG HLA specific antibodies to donor T and B lymphocytes measurement | Other |
| Detection of auto platelet antibodies | Detection of auto platelet antibodies | Other |
| Detection of chimerisms | Detection of chimerisms | Other |
| Detection of chimerisms measurement | Detection of chimerisms measurement | Other |
| Determination of HLA type | Determination of HLA type | Other |
| Determination of HNA type | Determination of HNA type | Other |
| Determination of HPA type | Determination of HPA type | Other |
| Determination of HPA-1a phenotype measurement | Determination of HPA-1a phenotype measurement | Other |
| Determination of IgA deficiency | Determination of IgA deficiency | Other |
| Determination of the expression of glycoproteins: GPIIb/IIIa | Determination of the expression of glycoproteins: GPIIb/IIIa | Other |
| Engraftment monitoring post stem cell transplant | Engraftment monitoring post stem cell transplant | Other |
| Engraftment monitoring post stem cell transplant measurement | Engraftment monitoring post stem cell transplant measurement | Other |
| Estimation of feto-maternal haemorrhage measurement | Estimation of feto-maternal haemorrhage measurement | Other |
| Fy3 | Fy3 | Other |
| GPIIb/IIIa, GPIb/IX, GPIa/IIa, GPIV, GPV | GPIIb/IIIa, GPIb/IX, GPIa/IIa, GPIV, GPV | Other |
| GPIIb/IIIa, GPIb/IX, GPIa/IIa, GPIV, GPV measurement | GPIIb/IIIa, GPIb/IX, GPIa/IIa, GPIV, GPV measurement | Other |
| GPIV measurement | GPIV measurement | Other |
| GPIa/IIa | GPIa/IIa | Other |
| GPIb/IX | GPIb/IX | Other |
| Genotyping | Genotyping | Other |
| Genotyping measurement | Genotyping measurement | Other |
| HLA -A, -B, -C, -DR, -DQ, -DP measurement | HLA -A, -B, -C, -DR, -DQ, -DP measurement | Other |
| HNA -1, - 3, -4, -5 | HNA -1, - 3, -4, -5 | Other |
| HPA -1, - 2, - 3, -4, -5, -6, -9, - 15 measurement | HPA -1, - 2, - 3, -4, -5, -6, -9, - 15 measurement | Other |
| Histocompatibility and Immunogenetics investigations for the purpose of clinical diagnosis | Histocompatibility and Immunogenetics investigations for the purpose of clinical diagnosis | Other |
| I, i | I, i | Other |
| Jk3 | Jk3 | Other |
| Lan | Lan | Other |
| Lu b , Lu3 | Lu b , Lu3 | Other |
| Molecular | Molecular | Other |
| Other antigens: Majority of known red blood cell antigens (currently comprises 356 antigens) | Other antigens: Majority of known red blood cell antigens (currently comprises 356 antigens) Molecular | Other |
| Red Cell Immunohaematology investigations for the purpose of clinical diagnosis | Red Cell Immunohaematology investigations for the purpose of clinical diagnosis | Other |
| Vel | Vel | Other |
| Yt a , Yt b | Yt a , Yt b | Other |
Send an Enquiry
Request a quote, ask about capacity, or discuss your testing requirements directly with this lab.